Ovarian NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorNeoplasms, Glandular and EpithelialAntineoplastic AgentsCisplatinGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmChemotherapy, AdjuvantBreast NeoplasmsTumor Cells, CulturedApoptosisMice, NudeCell ProliferationCystadenocarcinoma, SerousPaclitaxelNeoplasm InvasivenessXenograft Model Antitumor AssaysAntineoplastic Agents, PhytogenicCA-125 AntigenLung NeoplasmsNeoplasmsCombined Modality TherapyCell SurvivalCarcinomaDoxorubicinNeoplasm MetastasisRNA, Small InterferingNeoplasm StagingNeoplasm ProteinsPrognosisReverse Transcriptase Polymerase Chain ReactionTumor Markers, BiologicalDrug Screening Assays, AntitumorBlotting, WesternSurvival AnalysisRNA, MessengerSignal TransductionTreatment OutcomeCarboplatinColonic NeoplasmsPeritoneal NeoplasmsDisease-Free SurvivalAscitesCell MovementCell DivisionCell CycleCyclophosphamideSurvival RateDrug SynergismNeoplasm TransplantationAdenocarcinomaDose-Response Relationship, DrugTransfectionDown-RegulationCell Growth ProcessesGenes, BRCA1Adenocarcinoma, Clear CellTransplantation, HeterologousImmunohistochemistryStomach NeoplasmsPancreatic NeoplasmsCarcinoma, EndometrioidGene Expression ProfilingEarly Detection of CancerRNA InterferenceTumor Suppressor Protein p53Neoplasm Recurrence, LocalUp-RegulationDisease ProgressionFlow CytometryReceptor, erbB-2Proto-Oncogene Proteins c-aktTaxoidsOvaryDrug Administration ScheduleCystadenocarcinomaColorectal NeoplasmsDNA, NeoplasmGene Knockdown TechniquesOrganoplatinum CompoundsAdenocarcinoma, MucinousBRCA1 ProteinEtoposideAntibiotics, AntineoplasticAntimetabolites, AntineoplasticInhibitory Concentration 50Carcinoma, Non-Small-Cell LungTime FactorsLysophospholipidsBRCA2 ProteinPhosphorylationGene SilencingReceptors, EstrogenPlatinum CompoundsAntibodies, MonoclonalMutationPlatinumPromoter Regions, GeneticTumor Burden